Rankings
▼
Calendar
LNSR
LENSAR, Inc.
$142M
FY 2021 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$34M
+30.6% YoY
Gross Profit
$18M
51.8% margin
Operating Income
-$20M
-57.0% margin
Net Income
-$20M
-56.9% margin
EPS (Diluted)
$-2.10
Cash Flow
Operating Cash Flow
-$9M
Free Cash Flow
-$9M
Stock-Based Comp.
$7M
Balance Sheet
Total Assets
$66M
Total Liabilities
$12M
Stockholders' Equity
$55M
Cash & Equivalents
$32M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$34M
$26M
+30.6%
Gross Profit
$18M
$14M
+26.7%
Operating Income
-$20M
-$19M
-6.2%
Net Income
-$20M
-$20M
+0.9%
← Q4 2020
All Quarters
Q1 2021 →
LNSR FY 2021 Earnings — LENSAR, Inc. Revenue & Financial Results | Market Cap Arena